NDC 0270-7097
LumaSon .19 mg per 1 mg / 60.7 mg per 1 mg injection, powder, lyophilized, for suspension
On the label: Bracco Diagnostics Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Bracco Imaging Spa | Colleretto Giacosa, Italy | Makes it and tests it | Problems found, fixed voluntarilyNov 27, 2025 · 2 inspections |
| Bracco Suisse SA | Plan-les-Ouates, Switzerland | Makes it and tests it | Problems found, fixed voluntarilyJul 4, 2024 · 5 inspections, 1 with FDA action |
| Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Schuetzenstrasse) | Ravensburg, Germany | Makes it | Problems found, fixed voluntarilyJul 13, 2022 · 10 inspections |
Product details
- Generic drug
- Distearoylphosphatidylcholine, Dl- and Sodium 1,2-Dipalmitoyl-Sn-Glycero-3-Phospho-(1'-Rac-Glycerol) and Sulfur Hexafluoride: every company that makes it
- Form
- injection, powder, lyophilized, for suspension, intravenous; intravesical
- Strength
- .19 mg per 1 mg / 60.7 mg per 1 mg
- Approval
- NDA NDA203684
- On the market since
- Apr 1, 2021
- Package NDCs
0270-7097-07- Official label
- DailyMed (National Library of Medicine), updated Sep 9, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?